Differences in perceptions of community stigma towards opioid use disorder between community substance use coalition members and the general public
Copyright © 2023 Elsevier Inc. All rights reserved..
INTRODUCTION: To examine differences in perceptions about community stigma towards individuals with opioid use disorder (OUD) between community members involved in the opioid response (i.e., coalition members) and the general public, and how community geography may moderate this relationship.
METHODS: This study administered identical cross-sectional surveys about perceived community opioid-related stigma to two distinct populations in 66 communities participating in the HEALing Communities Study prior to the intervention period (i.e., coalition members, November 2019-January 2020; residents, March-April 2020). Linear-mixed models compared survey responses of populations, including the moderating effect of community rural/urban location.
RESULTS: A total of 826 coalition members and 1131 residents completed the surveys. The study found no differences between the coalition members and residents for general perceived community opioid-related stigma. In both urban and rural communities, coalition members reported greater perceived community stigma than residents reported towards medication for opioid use disorder (MOUD), naloxone, and drug treatment as an alternative to incarceration.
CONCLUSION: Our findings suggest similar perceived community opioid-related stigma between coalition members and residents, yet differences emerge related to evidence-based practices (i.e., MOUD, naloxone, and drug treatment as an alternative to incarceration) to reduce opioid overdose deaths.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04111939.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:158 |
|---|---|
| Enthalten in: |
Journal of substance use and addiction treatment - 158(2024) vom: 19. März, Seite 209276 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Walker, Daniel M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
36B82AMQ7N |
|---|
| Anmerkungen: |
Date Completed 18.03.2024 Date Revised 19.04.2024 published: Print-Electronic ClinicalTrials.gov: NCT04111939 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.josat.2023.209276 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36633459X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36633459X | ||
| 003 | DE-627 | ||
| 005 | 20240419232208.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231227s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.josat.2023.209276 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1380.xml |
| 035 | |a (DE-627)NLM36633459X | ||
| 035 | |a (NLM)38142801 | ||
| 035 | |a (PII)S2949-8759(23)00328-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Walker, Daniel M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Differences in perceptions of community stigma towards opioid use disorder between community substance use coalition members and the general public |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.03.2024 | ||
| 500 | |a Date Revised 19.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ClinicalTrials.gov: NCT04111939 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Elsevier Inc. All rights reserved. | ||
| 520 | |a INTRODUCTION: To examine differences in perceptions about community stigma towards individuals with opioid use disorder (OUD) between community members involved in the opioid response (i.e., coalition members) and the general public, and how community geography may moderate this relationship | ||
| 520 | |a METHODS: This study administered identical cross-sectional surveys about perceived community opioid-related stigma to two distinct populations in 66 communities participating in the HEALing Communities Study prior to the intervention period (i.e., coalition members, November 2019-January 2020; residents, March-April 2020). Linear-mixed models compared survey responses of populations, including the moderating effect of community rural/urban location | ||
| 520 | |a RESULTS: A total of 826 coalition members and 1131 residents completed the surveys. The study found no differences between the coalition members and residents for general perceived community opioid-related stigma. In both urban and rural communities, coalition members reported greater perceived community stigma than residents reported towards medication for opioid use disorder (MOUD), naloxone, and drug treatment as an alternative to incarceration | ||
| 520 | |a CONCLUSION: Our findings suggest similar perceived community opioid-related stigma between coalition members and residents, yet differences emerge related to evidence-based practices (i.e., MOUD, naloxone, and drug treatment as an alternative to incarceration) to reduce opioid overdose deaths | ||
| 520 | |a TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04111939 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Community coalitions | |
| 650 | 4 | |a Drug treatment | |
| 650 | 4 | |a MOUD | |
| 650 | 4 | |a Naloxone | |
| 650 | 4 | |a Opioid use disorder | |
| 650 | 4 | |a Stigma | |
| 650 | 7 | |a Analgesics, Opioid |2 NLM | |
| 650 | 7 | |a Naloxone |2 NLM | |
| 650 | 7 | |a 36B82AMQ7N |2 NLM | |
| 700 | 1 | |a Lefebvre, R Craig |e verfasserin |4 aut | |
| 700 | 1 | |a Davis, Alissa |e verfasserin |4 aut | |
| 700 | 1 | |a Shiu-Yee, Karen |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Sadie |e verfasserin |4 aut | |
| 700 | 1 | |a Jackson, Rebecca D |e verfasserin |4 aut | |
| 700 | 1 | |a Helme, Donald W |e verfasserin |4 aut | |
| 700 | 1 | |a Oga, Emmanuel A |e verfasserin |4 aut | |
| 700 | 1 | |a Oser, Carrie B |e verfasserin |4 aut | |
| 700 | 1 | |a Stotz, Caroline |e verfasserin |4 aut | |
| 700 | 1 | |a Balvanz, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Asman, Kat |e verfasserin |4 aut | |
| 700 | 1 | |a Holloway, JaNae |e verfasserin |4 aut | |
| 700 | 1 | |a Lewis, Nicky |e verfasserin |4 aut | |
| 700 | 1 | |a Knudsen, Hannah K |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of substance use and addiction treatment |d 2023 |g 158(2024) vom: 19. März, Seite 209276 |w (DE-627)NLM353076554 |x 2949-8759 |7 nnns |
| 773 | 1 | 8 | |g volume:158 |g year:2024 |g day:19 |g month:03 |g pages:209276 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.josat.2023.209276 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 158 |j 2024 |b 19 |c 03 |h 209276 | ||